Issue: March 2018
March 08, 2018
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Trial Scorecard: DECREASE-PCI
Issue: March 2018
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Analysis of the safety and efficacy of dual antiplatelet therapy (DAPT) vs. triple antiplatelet therapy in patients treated with drug-eluting stents for CAD.